2014
DOI: 10.1016/j.mgene.2014.04.005
|View full text |Cite
|
Sign up to set email alerts
|

A novel mutation of CLCNKB in a Japanese patient of Gitelman-like phenotype with diuretic insensitivity to thiazide administration

Abstract: The clinical phenotypes of patients with Bartter syndrome type III sometimes closely resemble those of Gitelman syndrome. We report a patient with mild, adult-onset symptoms, such as muscular weakness and fatigue, who showed hypokalemic metabolic alkalosis, elevated renin–aldosterone levels with normal blood pressure, hypocalciuria and hypomagnesemia. She was also suffering from chondrocalcinosis. A diuretic test with furosemide and thiazide showed a good response to furosemide, but little response to thiazide… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
6
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 31 publications
0
6
0
Order By: Relevance
“…Because patients excrete high levels of PGE2 with the urine and blockers of PGE2 synthesis significantly alleviate the symptoms, this variant is also called the "hyperprostaglandinuria syndrome". 6,[11][12][13][14][15] Finally, mutations in the BSND gene lead to type 4 BS, the most severe form of BS with extreme growth retardation, very severe salt-wasting, and sensorineural deafness. Nevertheless, patients related to CLCNKB show a high phenotypic variability with clinical presentations ranging from very severe salt-losing nephropathy with marked hypokalemia to almost asymptomatic presentation.…”
mentioning
confidence: 99%
“…Because patients excrete high levels of PGE2 with the urine and blockers of PGE2 synthesis significantly alleviate the symptoms, this variant is also called the "hyperprostaglandinuria syndrome". 6,[11][12][13][14][15] Finally, mutations in the BSND gene lead to type 4 BS, the most severe form of BS with extreme growth retardation, very severe salt-wasting, and sensorineural deafness. Nevertheless, patients related to CLCNKB show a high phenotypic variability with clinical presentations ranging from very severe salt-losing nephropathy with marked hypokalemia to almost asymptomatic presentation.…”
mentioning
confidence: 99%
“…Among other types of inherited tubulopathies, it comprises the most heterogeneous clinical presentation, as compared to GS phenotypes11). There was a report of a novel missense mutation of CLCNKB in a Japanese patient of Gitelman-like phenotype with diuretic insensitiviry to thiazide administration4). A diuretic test using furosemide and thiazide as well as clinical findings has been used to make a differential diagnosis between BS and GS, but there were some reports that showed the discrepancies between the diuretic test and genotype45).…”
Section: Discussionmentioning
confidence: 99%
“…There was a report of a novel missense mutation of CLCNKB in a Japanese patient of Gitelman-like phenotype with diuretic insensitiviry to thiazide administration4). A diuretic test using furosemide and thiazide as well as clinical findings has been used to make a differential diagnosis between BS and GS, but there were some reports that showed the discrepancies between the diuretic test and genotype45). It is recommended to perform the genetic test to diagnosis the hereditary tubulopathies.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Gitelman syndrome (GS) is an autosomal recessive renal tubular disease, first reported by Gitelman et al in 1966 [ 1 ]. GS is caused by a mutation in the SLC12A3 gene which encodes a thiazide-sensitive sodium chloride cotransporter (NCCT) [ 2 , 3 ]. CLCNKB mutations form the molecular basis of classical Bartter syndrome (cBS) as it encodes chloride channels in the renal tubular basement membrane [ 4 ].…”
Section: Introductionmentioning
confidence: 99%